SCIENTIFIC ADVISORY BOARD
Bernie Zeiher, MD
Bernie Zeiher has over 20 years of experience in drug development across a broad range of therapeutic areas.
Trained as a pulmonary and critical care physician, he has led the development of products in critical care, pain, immunology, and infectious diseases. He was involved in and oversaw the approval of over 15 products. He is passionate about addressing unmet patients’ needs in underserved and severe diseases. Dr. Zeiher has held increasing leadership and executive responsibility positions at Astellas, Pfizer and Lilly, including board memberships, CMO and President of Development.
Dr. Zeiher received his Doctor of Medicine from Case Western Reserve University School of Medicine and a Bachelor of Science in Biology from the University of Toledo.